Inhibition of lung tumorigenesis by transient reprogramming in cancer cells.

Autor: Pedrosa P; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Zhang Z; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Nuñez-Quintela V; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Macias D; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Ge J; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Denholm M; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dyas A; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Estevez-Souto V; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Lado-Fernandez P; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Department of Physiology and Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidad de Santiago de Compostela, Santiago de Compostela, Spain., Gonzalez P; Histopathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Gomez M; Histopathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martin JE; CMDL, Department of Oncology, SMCL, Department of Medical Genetics, University of Cambridge, Cambridge, UK., Da Silva-Alvarez S; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Collado M; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. manuel.collado.rodriguez@sergas.es.; Department of Immunology and Oncology (DIO), Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain. manuel.collado.rodriguez@sergas.es., Muñoz-Espín D; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK. dm742@cam.ac.uk.; CRUK Cambridge Centre Thoracic Cancer Programme, University of Cambridge, Cambridge, UK. dm742@cam.ac.uk.

Publikováno v: Cell death & disease [Cell Death Dis] 2024 Nov 25; Vol. 15 (11), pp. 857. Date of Electronic Publication: 2024 Nov 25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

GDF‐15 is associated with sarcopenia and frailty in acutely admitted older medical patients.

Autor: Kamper, Rikke S., Nygaard, Hanne, Praeger‐Jahnsen, Louis, Ekmann, Anette, Ditlev, Sisse Bolm, Schultz, Martin, Hansen, Sofie Krarup, Hansen, Pernille, Pressel, Eckart, Suetta, Charlotte

Publikováno v: Journal of Cachexia, Sarcopenia & Muscle; Aug2024, Vol. 15 Issue 4, p1549-1557, 9p

The life‐cycle and restoration of the human vocal fold.

Autor: Hamilton, Nick J. I.^1,2 (AUTHOR) nick.hamilton@ucl.ac.uk

Publikováno v: Laryngoscope Investigative Otolaryngology. Feb2023, Vol. 8 Issue 1, p168-176. 9p.